Omics-imaging signature-based nomogram to predict the progression-free survival of patients with hepatocellular carcinoma after transcatheter arterial chemoembolization

Figure 5 Line charts illustrating predictions of patients' 2-year progression-free survival probabilities using different multiphase radiomic features and multifactorial regression models. DTL: Deep transfer learning; DLR: Deep learning radiomics; PFS: Progression-free survival.